Table of contents

Key facts

Active substance
Durlobactam / sulbactam (SUL-DUR)
Therapeutic area
Infectious diseases
Decision number
PIP number
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of infections due to organisms of the Acinetobacter baumannii-calcoaceticus complex
Route(s) of administration
Intravenous use
Contact for public enquiries
Entasis Therapeutics Inc.

Email: Enquiries@entasistx.com
Tel. +1 7818108940

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)


How useful was this page?

Add your rating